Modified lysine-mimetic compounds
View Patent ↗Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
1. A method of treating ischemia, or ischemic injury in the organs of a mammal, comprising administering to a subject a therapeutically effective amount of a compound that is
or a pharmaceutically acceptable salt thereof.
2. The method according to claim 1 , for treating acute ischemic heart disease.
3. The method according to claim 1 , for treating stable or unstable angina pectoris.
4. The method according to claim 1 , for treating acute myocardial infarction.
5. The method according to claim 1 , for treating ischemic injury in the gastrointestinal tract.
6. The method according to claim 1 , wherein the subject is a human being.
7. The method according to claim 1 , wherein the compound is formulated for parenteral or oral administration.
8. A method of treating ischemia, or ischemic injury in the organs of a mammal, comprising administering to a subject a therapeutically effective amount of a compound that is
or a pharmaceutically acceptable salt thereof.
9. The method according to claim 8 , for treating acute ischemic heart disease.
10. The method according to claim 8 , for treating stable or unstable angina pectoris.
11. The method according to claim 8 , for treating acute myocardial infarction.
12. The method according to claim 8 , for treating ischemic injury in the gastrointestinal tract.
13. The method according to claim 8 , wherein the subject is a human being.
14. The method according to claim 8 , wherein the compound is formulated for parenteral or oral administration.